Immune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and enteric nervous system

M J Bern, C W Sturbaum, S S Karayalcin, H M Berschneider, J T Wachsman, D W Powell, M J Bern, C W Sturbaum, S S Karayalcin, H M Berschneider, J T Wachsman, D W Powell

Abstract

The role of the immune system in controlling intestinal electrolyte transport was studied in rat and rabbit colon in Ussing chambers. A phagocyte stimulus, the chemotactic peptide FMLP, and a mast cell stimulus, sheep anti-rat IgE, caused a brief (less than 10 min) increase in short-circuit current (Isc). Products of immune system activation, platelet-activating factor (PAF) and reactive oxygen species (ROS), caused a sustained, biphasic increase in the Isc. Ion replacement and flux studies indicated that these agonists stimulated electrogenic Cl secretion and inhibited neutral NaCl absorption; responses that were variably inhibited by the cyclooxygenase blockers indomethacin and piroxicam. Lesser degrees of inhibition by nordihydroguaiaretic acid could be accounted for by decreased prostaglandin synthesis rather than by lipoxygenase blockade. Tetrodotoxin, hexamethonium, and atropine also inhibited immune agonist-stimulated Isc, but had no effect on immune agonist-stimulated production of PGE2 or PGI2. These results indicate that immune system agonists alter intestinal epithelial electrolyte transport through release of cyclooxygenase products from cells in the lamina propria with at least 50% of the response being due to cyclooxygenase product activation of the enteric nervous system. The immune system, like the enteric nervous system and the endocrine system, may be a major regulating system for intestinal water and electrolyte transport in health and disease.

References

    1. J Clin Invest. 1971 Jun;50(6):1218-30
    1. Gastroenterology. 1986 Jun;90(6):1972-7
    1. J Membr Biol. 1976;27(3):297-316
    1. J Physiol. 1977 Nov;272(3):737-54
    1. Life Sci. 1987 Aug 3;41(5):527-44
    1. Acta Physiol Scand. 1987 Aug;130(4):633-42
    1. J Physiol. 1987 Jul;388:521-32
    1. Am J Physiol. 1987 Oct;253(4 Pt 1):G540-8
    1. Gastroenterology. 1988 Jan;94(1):127-36
    1. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):74-8
    1. Adv Prostaglandin Thromboxane Res. 1978;5:119-210
    1. Gastroenterology. 1980 Jan;78(1):32-42
    1. J Biol Chem. 1980 Nov 10;255(21):10223-6
    1. Curr Top Cell Regul. 1980;17:137-70
    1. J Pharm Pharmacol. 1981 Aug;33(8):521-5
    1. Med Clin North Am. 1981 Jul;65(4):809-28
    1. FEBS Lett. 1981 Sep 14;132(1):85-8
    1. Biochem Biophys Res Commun. 1982 Jan 15;104(1):247-53
    1. Inflammation. 1982 Mar;6(1):113-25
    1. Science. 1982 Sep 24;217(4566):1255-6
    1. Am J Physiol. 1982 Nov;243(5):G321-9
    1. Biochim Biophys Acta. 1982 Dec 13;713(3):684-7
    1. Am J Physiol. 1983 Apr;244(4):G386-91
    1. Int Arch Allergy Appl Immunol. 1983;72(1):34-40
    1. Br J Pharmacol. 1983 Oct;80(2):279-86
    1. Gastroenterology. 1984 Mar;86(3):453-60
    1. Prog Allergy. 1984;34:188-235
    1. Prog Allergy. 1984;34:271-321
    1. J Clin Invest. 1984 Apr;73(4):889-97
    1. Int Arch Allergy Appl Immunol. 1984;75(3):255-63
    1. Gut. 1984 Dec;25(12):1399-413
    1. Fed Proc. 1985 Jan;44(1 Pt 1):108-11
    1. J Immunol. 1985 Jul;135(1):483-91
    1. J Physiol. 1985 Jul;364:301-12
    1. Gastroenterology. 1986 Sep;91(3):746-68
    1. Am J Physiol. 1986 Oct;251(4 Pt 1):G509-17
    1. Z Gastroenterol. 1986 Sep;24 Suppl 3:70-8
    1. Prostaglandins. 1986 Sep;32(3):387-99
    1. Dig Dis Sci. 1987 Jan;32(1):71-5
    1. Am J Med. 1986 Dec 22;81(6B):74-82
    1. Am J Physiol. 1987 Jan;252(1 Pt 1):G120-7
    1. Int Arch Allergy Appl Immunol. 1987;82(3-4):238-43
    1. N Engl J Med. 1987 Jul 2;317(1):30-4
    1. Am J Physiol. 1987 Jun;252(6 Pt 1):G783-90
    1. Am J Physiol. 1985 Sep;249(3 Pt 1):C356-61
    1. Br J Pharmacol. 1985 Aug;85(4):787-95
    1. Am J Physiol. 1986 Apr;250(4 Pt 1):G427-31
    1. Am J Physiol. 1973 Nov;225(5):1232-9

Source: PubMed

3
Iratkozz fel